This webinar was part of the ICAP Grand Rounds Webinar series. Fred M. Gordin, Chief of Infectious Diseases from the Veterans Affairs Medical Center presented. The recording is available here.
Avac Event
START Study – Strategic Timing of Antiretroviral Treatment
Avac Event
Investing in Innovation: The Payoff for Women’s Sexual and Reproductive Health
IPM hosted an event, Investing in Innovation: The Payoff for Women’s Sexual and Reproductive Health, on the eve of the UN’s Sustainable Development Summit to adopt the new set of Sustainable Development Goals. IPM’s aim was to highlight the many benefits to be gained from investing in innovative solutions to improve the sexual and reproductive health and rights (SRHR) of women and girls.
The panelists included:
- Zeda Rosenberg, CEO, International Partnership for Microbicides
- Julia Bunting, President, Population Council
- Georgina Caswell, Regional Technical Advisor, International HIV/AIDS Alliance
- Robin Gorna, Executive Director, Partnership for Maternal, Newborn & Child Health (PMNCH)
- Katja Iversen, Chief Executive Officer, Women Deliver
- Jaak Peeters, Global Head, Johnson & Johnson Global Public Health
Avac Event
New WHO Guidelines for HIV Testing Services Webinar
A critical first step in achieving the 90-90-90 targets proposed by UNAIDS is ensuring that 90 percent of all people living with HIV will know their HIV status by 2020. This is an ambitious goal, as currently only half of people living with HIV know their status. The recently released WHO HIV testing guidelines address and respond to this reality. The WHO’s Dr. Rachel Baggaley, unpacked the HIV testing guidelines and highlighted the need-to-know specifics of the new guidelines.
Listen to the recording here.
View the slides here.
Avac Event
EATG 2015 Webinar 1: An update on PrEP in Europe
This series of three webinars, hosted jointly by EATG and AVAC, is designed to prepare and update EATG members for a special meeting on new developments in prevention January 29-31, 2016 in Brussels.
The first webinar addressed the latest updates on PrEP in Europe. Speakers: Dr Valentina Cambiano of University College London, Daniela Rojas Castro of AIDES and Dr Anastasia Pharris of the European Centre for Disease Prevention and Control (ECDC).
Chaired by Gus Cairns of EATG.
Please note that the recording starts a few minutes into Gus Cairns introduction.
Avac Event
PrEP, Possibility, Pregnancy and Breastfeeding
The US Women and PrEP working group discussed PrEP, pregnancy and breastfeeding on October 5. A recording of the webinar can be found here.
Avac Event
WHO Guidelines on when to start antiretroviral therapy and on pre-exposure prophylaxis for HIV
WHO recently issued an “Early Release Guideline” on when to start antiretroviral therapy and on pre-exposure prophylaxis (PrEP) for HIV. This document recommends 1) initiation of ART in adults living with HIV, regardless of CD4 cell count, and 2) offer of PrEP as a prevention option to all people at substantial risk of acquiring HIV. (The release is “early” relative to a comprehensive update of its consolidated ARV guidelines, slated to come out at the end of the year.) If implemented, these sweeping recommendations have the potential to change the world by simplifying ART for people living with HIV and revolutionizing prevention for people at risk.
In this webinar, Meg Doherty and Bob Grant from the Department of HIV/AIDS at WHO, spoke about the guideline and took questions. Links to the full presentation, slides and audio are below.
And for more background, Meg Doherty gave a presentation at IAS 2015 in Vancouver. Download the slides or view the presentation.
Avac Event
The Next Generation of Global Health: Harnessing innovation to ensure healthy lives for all
US leadership in global health innovation has played a critical role in achieving landmark progress in global health over the past fifteen years. As the global community embarks on the next era of development, the Sustainable Development Goals (SDGs) challenge us to reach for zero and eliminate poverty, infectious disease outbreaks, and preventable maternal and child deaths.
The end of HIV/AIDs, malaria, tuberculosis, neglected tropical diseases and preventable deaths during childbirth are only within reach if we continue to invest in the research and development for new vaccines, drugs and devices that move us beyond current health interventions.
The Global Health Technologies Coalition had an interactive panel discussion on how global health innovation is key to tackling the world’s most pressing health issues and meeting the challenge of the Sustainable Development Goals. The panel highlighted the importance of partnerships, especially the role of the private sector, nonprofits and US Government in global health innovation.
A panel discussion with:
- Kaitlin Christenson, PATH
- Gary Cohen, Becton, Dickinson and Company
- Dean Jamison, Lancet Commission on Investing in Health
- Tony Pipa, US Department of State
- Moderated by Lisa Cohen, Washington Global Health Alliance
In Collaboration with:
- Senator Roger Wicker and Senator Chris Coons, co-chairs of the Senate Caucus on Malaria and Neglected Tropical Diseases
- Congressman Ander Crenshaw and Congressman Gregory Meeks, co-chairs of the Congressional Malaria and Neglected Tropical Diseases Caucus
Avac Event
EATG 2015 webinar 2: Treatment for all: prevention and community implications
Following the recent announcement of new guidelines by WHO, this webinar looked at the implications of treatment for all for HIV prevention programmes.
Speakers included Professor Jens Lundgren, one of the principal investigators of the START study; Dr Meg Doherty, Coordinator of Treatment and Care in the Department of HIV/AIDS at WHO, and Giulio Maria Corbelli, Chair of the European Community Advisory Board (ECAB).
The webinar was chaired by Gus Cairns of EATG.
Avac Event
Strategies and Best Practices for Recruitment and Retention of Cisgender & Transgender Women in HIV Clinical Trials
The Centers for Disease Control reports nearly one in four people living with HIV in the United States is female. Federal funding has been allocated to increase awareness and inclusion of women in clinical trials, yet female participants are often underrepresented in HIV research.
Transgender women also encounter a high prevalence of HIV infection, but have not sufficiently been included in clinical trials. The National HIV AIDS Strategy states that although progress has been made in recent years the Federal government “must remain vigilant in increasing knowledge and appropriate support and interventions” for transgender communities.
The webinar featured:
- Annet Davis, RN, MSW, CCRC, Project Director, at University of Pennsylvania’s HIV Prevention Research Division. She will speak to her success in engaging women with transgender experiences for HVTN 505, a Phase 2b HIV vaccine trial.
- Rondalya DeShields, RN, MSN, Program Manager for the Infectious Disease Practice at Rutgers, New Jersey Medical School. She will speak on recruiting high risk women for HPTN 069, also known as NEXT-PrEP, a Phase 2 trial of maraviroc as PrEP.
These studies demonstrate some of the unique considerations that are necessary for successfully engaging cisgender and transgender women in HIV research.
The Women’s HIV Research Collaborative (WHRC), a working group of the Legacy Project, provides culturally appropriate leadership in development, implementation and dissemination of information about HIV research addressing the needs of women and girls in the United States. The WHRC works to raise the visibility of issues related to HIV in women in the US and promotes awareness of scientific research to women in disproportionately impacted communities.
Avac Event
The Combine! Study: Protocol for a Pragmatic Clinical Trial on PEP, PrEP and Combination HIV Prevention Methods in Public Clinics in Brazil
The Network for Multidisciplinary Studies on ARV-Based HIV Prevention (NEMUS) webinar was presented by Dr. Eliana Miura Zucchi on:
The Combine! Study: Protocol for a Pragmatic Clinical Trial on PEP, PrEP and Combination HIV Prevention Methods in Public Clinics in Brazil
Dr. Eliana Miura Zucchi is a psychologist with masters (2008) and doctoral (2014) degrees in public health from the University of Sao Paulo. Currently she teaches at the Graduate Program in Collective Health at the Catholic University of Santos, and is a member of NEPAIDS – the Center for HIV Prevention Studies at the University of Sao Paulo. She is part of the Research Team of the Combine! Study.